@Article{biocell.2022.022924,
AUTHOR = {MONICA SAVIO, VALENTINA MINOIA, PAOLA FULGHIERI, LUCIA ANNA STIVALA, VIRGINIE SOTTILE},
TITLE = {Resveratrol-related compounds: Potential for cancer and beyond},
JOURNAL = {BIOCELL},
VOLUME = {46},
YEAR = {2022},
NUMBER = {12},
PAGES = {2525--2530},
URL = {http://www.techscience.com/biocell/v46n12/49274},
ISSN = {1667-5746},
ABSTRACT = {The nutraceutical resveratrol is associated with a range of biological effects, from antibiotic to anti-inflammatory activities. One major axis of research has sought to harness its anti-tumour potential, with promising preclinical results and early clinical trials. A second strong interest relies on the anti-ageing effects ascribed to the compound and its application to stem cell research. It is becoming clear however that these possible favourable effects are conditioned by a set concentration range not easily controllable <i>in vivo</i>. Here we evoke novel developments in the field that could lead to more reliable conditions for the translational use of resveratrol-based compounds.},
DOI = {10.32604/biocell.2022.022924}
}